List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2019-2024)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2025-2030)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2019-2024)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2019-2024)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2025-2030)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2019-2024)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2025-2030)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 52. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. Accelerate Diagnostics Company Detail
Table 55. Accelerate Diagnostics Business Overview
Table 56. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 57. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 58. Accelerate Diagnostics Recent Development
Table 59. BD Company Detail
Table 60. BD Business Overview
Table 61. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 62. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 63. BD Recent Development
Table 64. bioMrieux Company Detail
Table 65. bioMrieux Business Overview
Table 66. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 67. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 68. bioMrieux Recent Development
Table 69. Bio-Rad Company Detail
Table 70. Bio-Rad Business Overview
Table 71. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 73. Bio-Rad Recent Development
Table 74. DiaSorin Molecular Company Detail
Table 75. DiaSorin Molecular Business Overview
Table 76. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 77. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 78. DiaSorin Molecular Recent Development
Table 79. F. Hoffmann-La Roche Company Detail
Table 80. F. Hoffmann-La Roche Business Overview
Table 81. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 82. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 83. F. Hoffmann-La Roche Recent Development
Table 84. Luminex Company Detail
Table 85. Luminex Business Overview
Table 86. Luminex Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 88. Luminex Recent Development
Table 89. Meridian Bioscience Company Detail
Table 90. Meridian Bioscience Business Overview
Table 91. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 92. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 93. Meridian Bioscience Recent Development
Table 94. OpGen Company Detail
Table 95. OpGen Business Overview
Table 96. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 97. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 98. OpGen Recent Development
Table 99. QIAGEN Company Detail
Table 100. QIAGEN Business Overview
Table 101. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 102. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 103. QIAGEN Recent Development
Table 104. Quidel Company Detail
Table 105. Quidel Business Overview
Table 106. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 107. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 108. Quidel Recent Development
Table 109. Thermo Fisher Scientific Company Detail
Table 110. Thermo Fisher Scientific Business Overview
Table 111. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 112. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 113. Thermo Fisher Scientific Recent Development
Table 114. Trinity Biotech Company Detail
Table 115. Trinity Biotech Business Overview
Table 116. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 117. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 118. Trinity Biotech Recent Development
Table 119. Danaher Company Detail
Table 120. Danaher Business Overview
Table 121. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 122. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 123. Danaher Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Urinary Tract Infections Features
Figure 4. Surgical Site Infections Features
Figure 5. Hospital-acquired Pneumonia Features
Figure 6. BloodStream Infections Features
Figure 7. Gastrointestinal Infections Features
Figure 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. ASCs Case Studies
Figure 13. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2023 VS 2030
Figure 17. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2023
Figure 18. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2023
Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)
Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)
Figure 26. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2019-2030)
Figure 34. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)
Figure 42. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)
Figure 46. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 49. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 50. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 51. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 53. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 55. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 56. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 57. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 58. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 59. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 61. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 62. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed